Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant for Excessive Daytime Sleepiness in Narcolepsy (HARMONY III)
NCT01399606Phase 3Completed
- Sponsor
- Bioprojet
- Start
- May 2011
- Primary completion
- Oct 2013
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pitolisant in narcolepsy and cataplexy, sponsored by Bioprojet. Primary endpoint: Treatment Emergent Adverse Event at 12 months. Started May 2011; status: completed.
02
Drugs
pitolisant
03
Conditions
narcolepsycataplexy
Beyond the preview
Go deeper on NCT01399606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01399606.